#ArtificialIntelligence

Oncology

Dr Michael Bauer on Quantro’s mission to drug the “undruggab...

Jonah Comstock reunited with Dr Michael Bauer, CEO of Quantro Therapeutics, at LSX 2026 to discuss the company's progress.

Digital

BIO-Europe Spring interview with Dr Olga Nissan

On collaboration, computational chemistry, and cutting-edge ...

Dr Olga Nissan, vice president of business development at Evogene discusses collaboration with Google Cloud & generative design of small molecules.

Market Access

Is AI the missing link in fixing MLR – or the reason it brea...

Somewhere in a shared drive at a mid-size pharma company, there is a folder labelled “Q3 Messaging FINAL v3 (2).” Inside it are three Word documents with tracked changes from four people, n

Digital

We can’t fix modern healthcare with 1950s solutions. AI is t...

In today’s NHS, the urgency of embracing artificial intelligence (AI) is no longer a matter of innovation - it’s a matter of survival.

Patients

Responding to global greying: Does Nordic AgeTech hold the b...

It’s a fact of life that we’re all living longer, which is reshaping the way healthcare is delivered.

Digital

What is the future of technology in health data?

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things.

Dr Michael Bauer on Quantro’s mission to drug the “undruggab...

On collaboration, computational chemistry, and cutting-edge ...

Is AI the missing link in fixing MLR – or the reason it brea...

We can’t fix modern healthcare with 1950s solutions. AI is t...

Responding to global greying: Does Nordic AgeTech hold the b...

What is the future of technology in health data?

argenx's Forte acquisition delivers coeliac trial win

Discover a new era of healthcare panel engagement: Grounded ...

#ArtificialIntelligence

Editor's Picks